Diabetic cardiomyopathy - A comprehensive updated review Article

Full Text via DOI: 10.1016/j.pcad.2019.03.003 PMID: 30922976 Web of Science: 000498332300005

Cited authors

  • Murtaza, Ghulam; Virk, Hafeez Ul Hassan; Khalid, Muhammad; Lavie, Carl J.; Ventura, Hector; Mukherjee, Debabrata; Ramu, Vijay; Bhogal, Sukhdeep; Kumar, Gautam; Shanmugasundaram, Madhan; Paul, Timir K.


  • Diabetes causes cardiomyopathy and increases the risk of heart failure independent of hypertension and coronary heart disease. This condition called "Diabetic Cardiomyopathy" (DCM) is becoming a well-known clinical entity. Recently, there has been substantial research exploring its molecular mechanisms, structural and functional changes, and possible development of therapeutic approaches for the prevention and treatment of DCM. This review summarizes the recent advancements to better understand fundamental molecular abnormalities that promote this cardiomyopathy and novel therapies for future research. Additionally, different diagnostic modalities, up to date screening tests to guide clinicians with early diagnosis and available current treatment options has been outlined. (C) 2019 Elsevier Inc. All rights reserved.

Publication date

  • 2019

Published in

International Standard Serial Number (ISSN)

  • 0033-0620

Start page

  • 315

End page

  • 326


  • 62


  • 4